IBDEI2VZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48471,0)
 ;;=I69.391^^216^2407^22
 ;;^UTILITY(U,$J,358.3,48471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48471,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,48471,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,48471,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,48472,0)
 ;;=I69.191^^216^2407^23
 ;;^UTILITY(U,$J,358.3,48472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48472,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,48472,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,48472,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,48473,0)
 ;;=I69.291^^216^2407^25
 ;;^UTILITY(U,$J,358.3,48473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48473,1,3,0)
 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,48473,1,4,0)
 ;;=4^I69.291
 ;;^UTILITY(U,$J,358.3,48473,2)
 ;;=^5007485
 ;;^UTILITY(U,$J,358.3,48474,0)
 ;;=I69.091^^216^2407^24
 ;;^UTILITY(U,$J,358.3,48474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48474,1,3,0)
 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,48474,1,4,0)
 ;;=4^I69.091
 ;;^UTILITY(U,$J,358.3,48474,2)
 ;;=^5007421
 ;;^UTILITY(U,$J,358.3,48475,0)
 ;;=I69.891^^216^2407^26
 ;;^UTILITY(U,$J,358.3,48475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48475,1,3,0)
 ;;=3^Dysphagia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,48475,1,4,0)
 ;;=4^I69.891
 ;;^UTILITY(U,$J,358.3,48475,2)
 ;;=^5007547
 ;;^UTILITY(U,$J,358.3,48476,0)
 ;;=I69.321^^216^2407^27
 ;;^UTILITY(U,$J,358.3,48476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48476,1,3,0)
 ;;=3^Dysphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,48476,1,4,0)
 ;;=4^I69.321
 ;;^UTILITY(U,$J,358.3,48476,2)
 ;;=^5007492
 ;;^UTILITY(U,$J,358.3,48477,0)
 ;;=I69.121^^216^2407^28
 ;;^UTILITY(U,$J,358.3,48477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48477,1,3,0)
 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,48477,1,4,0)
 ;;=4^I69.121
 ;;^UTILITY(U,$J,358.3,48477,2)
 ;;=^5007428
 ;;^UTILITY(U,$J,358.3,48478,0)
 ;;=I69.021^^216^2407^29
 ;;^UTILITY(U,$J,358.3,48478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48478,1,3,0)
 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,48478,1,4,0)
 ;;=4^I69.021
 ;;^UTILITY(U,$J,358.3,48478,2)
 ;;=^5007396
 ;;^UTILITY(U,$J,358.3,48479,0)
 ;;=I69.821^^216^2407^31
 ;;^UTILITY(U,$J,358.3,48479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48479,1,3,0)
 ;;=3^Dysphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,48479,1,4,0)
 ;;=4^I69.821
 ;;^UTILITY(U,$J,358.3,48479,2)
 ;;=^5007523
 ;;^UTILITY(U,$J,358.3,48480,0)
 ;;=I69.221^^216^2407^30
 ;;^UTILITY(U,$J,358.3,48480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48480,1,3,0)
 ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,48480,1,4,0)
 ;;=4^I69.221
 ;;^UTILITY(U,$J,358.3,48480,2)
 ;;=^5007460
 ;;^UTILITY(U,$J,358.3,48481,0)
 ;;=G11.1^^216^2407^32
 ;;^UTILITY(U,$J,358.3,48481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48481,1,3,0)
 ;;=3^Early-onset cerebellar ataxia
 ;;^UTILITY(U,$J,358.3,48481,1,4,0)
 ;;=4^G11.1
 ;;^UTILITY(U,$J,358.3,48481,2)
 ;;=^5003753
 ;;^UTILITY(U,$J,358.3,48482,0)
 ;;=I69.392^^216^2407^33
 ;;^UTILITY(U,$J,358.3,48482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48482,1,3,0)
 ;;=3^Facial weakness following cerebral infarction
 ;;^UTILITY(U,$J,358.3,48482,1,4,0)
 ;;=4^I69.392
 ;;^UTILITY(U,$J,358.3,48482,2)
 ;;=^5007517
 ;;^UTILITY(U,$J,358.3,48483,0)
 ;;=I69.192^^216^2407^34
